Lin et al. developed cationic liposomes functionalized with GE-11 peptide to dual-target gemcitabine and HIF1α-siRNA (GE-GML/siRNA) for pancreatic cancer treatment through the specifically bind of GE-11 peptide to EGFR overexpressed. The gene discussed is HIF1A; the disease is familial pancreatic carcinoma.